Boston Bio Systems Announces Major Corporate Changes, Including New Auditor Appointment

BOSTON BIO SYSTEMS LTD. (BSE: 531458), a company listed on the BSE, has announced significant corporate changes following a board meeting held on September 4, 2025. The company has made several key decisions that will shape its future operations and governance structure.

New Statutory Auditor Appointed

The Board of Directors has accepted the resignation of M/s Nahar V & Company, the company's previous statutory auditors, effective September 4, 2025. The resignation was attributed to the auditor's pre-occupation with other assignments. In response, the Board has approved the appointment of M/s Sunit M Chhatbar & Co., Chartered Accountants, as the new Statutory Auditor to fill the casual vacancy.

M/s Sunit M Chhatbar & Co., with Firm Registration No. 141068W, is set to serve until the conclusion of the 30th Annual General Meeting (AGM). The Board has also proposed their appointment for a term of five consecutive years, from the 30th AGM to the 35th AGM, subject to shareholder approval.

Changes to Company's Foundational Documents

In a move to align with the Companies Act 2013, the Board has approved several alterations to the company's core documents:

1. Memorandum of Association (MOA): The Board has approved changes to the object clause of the MOA. New objects have been added, expanding the company's potential business activities to include:

   • Information technology services and software development
   • Agricultural production and processing
   • Real estate development
   • Trading and e-commerce operations

2. Articles of Association (AOA): A new set of Articles of Association has been approved to replace the existing ones, which were based on the older Companies Act, 1956.

These changes are subject to shareholder approval and are aimed at providing the company with greater flexibility in its operations and aligning its governance structure with current regulatory requirements.

Other Key Decisions

• The Board has approved the Board Report for the year ended March 31, 2025.
• The Notice for the 30th Annual General Meeting has been approved.
• M/s. Sumit Bajaj & Associates, Practicing Company Secretaries, has been appointed as the Scrutinizer for electronic voting during the upcoming AGM.

These developments signify a period of transition and potential growth for Boston Bio Systems. The appointment of new auditors and the proposed changes to the company's foundational documents indicate a strategic move towards modernizing the company's operations and governance structure.

Shareholders will have the opportunity to vote on these significant changes at the upcoming 30th Annual General Meeting. The date for this meeting has not been specified in the available information.

Investors and stakeholders are advised to keep an eye on further announcements from the company regarding the implementation of these changes and the date of the upcoming AGM.